Merck & Company Inc (MRK)

110.98
+0.13(+0.12%)
  • Volume:
    319,927
  • Day's Range:
    110.85 - 111.36
  • 52 wk Range:
    71.97 - 111.36
Trading near 52-week High

Merck&Co has hit the highest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

MRK Overview

Prev. Close
110.85
Day's Range
110.85-111.36
Revenue
58.61B
Open
110.98
52 wk Range
71.97-111.36
EPS
6.03
Volume
319,927
Market Cap
282.14B
Dividend (Yield)
2.92
(2.63%)
Average Volume (3m)
9,133,594
P/E Ratio
16.24
Beta
0.39
1-Year Change
51.41%
Shares Outstanding
2,535,395,974
Next Earnings Date
Feb 02, 2023
What is your sentiment on Merck&Co?
or
Vote to see community's results!

Merck & Company Inc News

Merck & Company Inc Analysis

Merck & Company Inc Company Profile

Merck & Company Inc Company Profile

Employees
67500

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Read More

Analyst Price Target

Average109.61 (-1.13% Downside)
High125.00
Low97.00
Price110.86
No. of Analysts27
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
  • covid vaccine pill approval!!
    2
    • MRK Gliding to 85 Hold till then
      1
      • Expected to bounce back, healthcare segment is the only one in business. And with the surge in rx drugs demand and shortages due to the covid situation. Its expected to bounce back in april
        3
        • Yesterday
          0
          • when should I sell?
            0
            • when should I sell?
              0
              • when should I sell?
                0